|
Rear Admiral Villforth is past-President and Executive Director of The Food and Drug Law Institute a non-profit organization whose mission is to increase knowledge about the laws and regulations pertaining to foods drugs cosmetics medical devices and biological products. He was a Commissioned Officer in the U.S. Public Health Service in the Department of Health and Human Services for 29 years the last 19 years of which he was assigned to the Food and Drug Administration (FDA) where he served as Director Center for Devices and Radiological Health. He retired from the Public Health Service in 1990 with the rank of Assistant Surgeon General (Rear Admiral). In 2002 he was appointed Chairman of the Board of the FDA Alumni Association. Rear Admiral Villforth has served on the boards of MiniMed Inc. a world leader in diabetes management systems Target Therapeutics Inc. a medical device company subsequently acquired by Boston Scientific Corp. and BRI International a contract research organization for the biotechnology pharmaceutical and medical devices industries subsequently acquired by Quintiles Transnational Corp. He currently serves on the board of EduNeering Inc. Rear Admiral Villforth joined Vasogen’s Board in 2001. | 